Clinical Trial: Early and Late Neutrophil CD64 and Monocyte HLA-DR as Biomarkers for Septic Shock

U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07401329) titled 'Early and Late Neutrophil CD64 and Monocyte HLA-DR as Biomarkers for Septic Shock' on Jan. 14.

Brief Summary: Study Summary: Neutrophil CD64 & Monocyte HLA-DR in Septic Shock

What is studied?

Doctors looked at two blood markers:

* Neutrophil CD64 (nCD64): rises quickly when the body fights infection.

* Monocyte HLA-DR (mHLA-DR): falls when the immune system becomes weak or "paralyzed." They also calculated a Sepsis Index (ratio of nCD64 to HLA-DR) to see how these markers change in patients with septic shock.

Why is this important? Septic shock is a severe form of sepsis that can cause organ failure and death. Early detection a...